Search Results 7701-7710 of 40221 for oral
Julie Ferris-Tillman, Ph.D. January 21, 2026. New CT imaging oral contrast agent improves visualization of bowel anatomy ...
New CT imaging oral contrast agent improves visualization of bowel anatomy, clinical trial data show. Cancer. New CT imaging oral contrast agent improves ...
D. January 21, 2026. New CT imaging oral contrast agent improves visualization of bowel anatomy ...
New CT imaging oral contrast agent improves visualization of bowel anatomy, clinical trial data show · Mayo Clinic researchers use AI to predict patient falls ...
ALLN-177 is an oral formulation of a recombinant, oxalate specific, microbial enzyme oxalate decarboxylase intended to treat secondary hyperoxaluria by ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!